Sotera Health Company
SHC
17.90
-0.35
-1.92%
Sotera Health Company
US · SHC
#2097 by market cap
Listed 2020
17.90
-0.35
-1.92%
Live - 5344 symbols - heartbeat 221s ago
· 2026-10-08 06:25
Pre-market
17.77
-0.74%
After-hours
17.90
0.00%
- Market cap
- 5.11B
- P/E (TTM)i
- 31.40
- P/Bi
- 7.67
- EPSi
- 0.27
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on SHC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Buy
Avg price target
23.67 +32.2%
Price target rangecurrent 17.90
Low22.00
Avg23.67
High25.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-20 | Goldman Sachs | -- | BUY | 24.00 |
| 2026-09-18 | Piper Sandler | -- | BUY | 25.00 |
| 2026-09-08 | Piper Sandler | -- | BUY | 25.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 25.00 |
| 2026-08-07 | Citi | -- | BUY | 25.00 |
| 2026-08-07 | Barclays | -- | BUY | 22.00 |
| 2026-08-06 | BMO Capital | -- | BUY | 22.00 |
| 2026-08-06 | Goldman Sachs | -- | BUY | 24.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 24.00 |
| 2026-07-14 | Goldman Sachs | -- | BUY | 22.00 |
| 2026-07-08 | RBC Capital | -- | BUY | 24.00 |
| 2026-06-24 | Barclays | -- | BUY | 19.00 |
| 2026-06-10 | Piper Sandler | -- | BUY | 22.00 |
| 2026-06-05 | Goldman Sachs | -- | BUY | 20.00 |
| 2026-05-22 | RBC Capital | -- | BUY | 24.00 |
| 2026-05-06 | Piper Sandler | -- | BUY | 22.00 |
| 2026-05-06 | Barclays | -- | BUY | 18.00 |
| 2026-05-06 | RBC Capital | -- | BUY | 24.00 |
| 2026-05-05 | BMO Capital | -- | BUY | 20.00 |
| 2026-05-04 | Piper Sandler | -- | BUY | 24.00 |
| 2026-04-15 | RBC Capital | -- | BUY | 24.00 |
| 2026-04-14 | Barclays | -- | BUY | 18.00 |
| 2026-04-01 | Barclays | -- | BUY | 20.00 |
| 2026-04-01 | RBC Capital | -- | BUY | 24.00 |
| 2026-03-17 | Piper Sandler | -- | BUY | 24.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Piper Sandler moved from Hold to Buy on 2026-01-09.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-01-09 | Piper Sandler | HOLD → BUY | 24.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±11.81% | +5.17% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±14.68% | -0.39% (in line) |
| 2025/Q4 | 2026-02-24 | -- | ±11.72% | -4.40% (in line) |
| 2025/Q3 | 2025-11-04 | -- | ±12.04% | -1.08% (in line) |
| 2025/Q2 | 2025-08-08 | -- | ±20.23% | +24.51% (beat) |
| 2025/Q1 | 2025-05-01 | -- | ±11.25% | +5.22% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±19.06% | -9.97% (in line) |
| 2024/Q3 | 2024-11-05 | -- | ±9.49% | -2.41% (in line) |
| 2024/Q2 | 2024-08-05 | -- | ±17.39% | +7.56% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±17.05% | -3.19% (in line) |
| 2023/Q4 | 2024-02-27 | -- | ±12.69% | +1.64% (in line) |
| 2023/Q3 | 2023-11-01 | -- | ±11.14% | +1.66% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:25:30 · For reference only, not investment advice and not tailored to your situation.